Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates -: art. no. 20

被引:67
作者
Godoy, APO [1 ]
Ribeiro, ML [1 ]
Benvengo, YHB [1 ]
Vitiello, L [1 ]
Miranda, MDB [1 ]
Mendonça, S [1 ]
Pedrazzoli, J [1 ]
机构
[1] Univ Sao Francisco, Sch Med, Clin Pharmacol & Gastroenterol Unit, BR-12900000 Braganca Paulista, SP, Brazil
关键词
D O I
10.1186/1471-230X-3-20
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: In this study, we evaluated the prevalence of primary resistance of Brazilian H. pylori isolates to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone. In addition, the vacA, iceA, cagA and cagE genotypes of strains isolated from Brazilian patients were determined and associated with clinical data in an effort to correlate these four virulence markers and antibiotic resistance. Methods: H. pylori was cultured in 155 H. pylori-positive patients and MICs for metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone were determined by the agar dilution method. Genomic DNA was extracted, and allelic variants of vacA, iceA, cagA and cagE were identified by the polymerase chain reaction. Results: There was a strong association between the vacA sI/cagA-positive genotype and peptic ulcer disease (OR=5.42, 95% CI 2.6-11.3, p=0.0006). Additionally, infection by more virulent strains may protect against GERD, since logistic regression showed a negative association between the more virulent strain, vacA sI/cagA-positive genotype and GERD (OR=0.26, 95% CI 0.08-0.8, p=0.03). Resistance to metronidazole was detected in 75 patients (55%), to amoxicillin in 54 individuals (38%), to clarithromycin in 23 patients (16%), to tetracycline in 13 patients (9%), and to furazolidone in 19 individuals (13%). No significant correlation between pathogenicity and resistance or susceptibility was detected when MIC values for each antibiotic were compared with different vacA, iceA, cagA and cagE genotypes. Conclusion: The analysis of virulence genes revealed a specific association between H. pylori strains and clinical outcome, furthermore, no significant association was detected among pathogenicity and resistance or susceptibility.
引用
收藏
页数:6
相关论文
共 37 条
[31]   Role of corpus gastritis and cagA-positive Helicobacter pylori infection in reflux esophagitis [J].
Queiroz, DMM ;
Rocha, GA ;
de Oliveira, CA ;
Rocha, AMC ;
Santos, A ;
Cabral, MMDA ;
Nogueira, AMMF .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (08) :2849-2853
[32]   GENE STRUCTURE OF THE HELICOBACTER-PYLORI CYTOTOXIN AND EVIDENCE OF ITS KEY ROLE IN GASTRIC DISEASE [J].
TELFORD, JL ;
GHIARA, P ;
DELLORCO, M ;
COMANDUCCI, M ;
BURRONI, D ;
BUGNOLI, M ;
TECCE, MF ;
CENSINI, S ;
COVACCI, A ;
XIANG, ZY ;
PAPINI, E ;
MONTECUCCO, C ;
PARENTE, L ;
RAPPUOLI, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (05) :1653-1658
[33]   Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment [J].
van Doorn, LJ ;
Schneeberger, PM ;
Nouhan, N ;
Plaisier, AP ;
Quint, WGV ;
de Boer, WA .
GUT, 2000, 46 (03) :321-326
[34]   Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori [J].
van Doorn, LJ ;
Figueiredo, C ;
Sanna, R ;
Plaisier, A ;
Schneeberger, P ;
De Boer, W ;
Quint, W .
GASTROENTEROLOGY, 1998, 115 (01) :58-66
[35]   Metronidazole and clarithromycin resistance in Helicobacter pylori determined by measuring MICs of antimicrobial agents in color indicator egg yolk Agar in a miniwell format [J].
Vasquez, A ;
Valdez, Y ;
Gilman, RH ;
McDonald, JJ ;
Westblom, TU ;
Berg, D ;
Mayta, H ;
Gutierrez, V ;
Berendson, R ;
LeonBarua, R ;
RamirezRamos, A ;
RecavarrenArce, S ;
Watanabe, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (05) :1232-1234
[36]   Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis [J].
Werdmuller, BFM ;
Loffeld, RJLF .
DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (01) :103-105
[37]   Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome:: Studies in four different countries [J].
Yamaoka, Y ;
Kodama, Y ;
Gutierrez, O ;
Kim, JG ;
Kashima, K ;
Graham, DY .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (07) :2274-2279